Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04672434
Recruitment Status : Recruiting
First Posted : December 17, 2020
Last Update Posted : July 2, 2021
Sponsor:
Information provided by (Responsible Party):
Symphogen A/S

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2024
Estimated Study Completion Date : March 2024